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We thank Huang and colleagues [1] for their positive comments on our recent meta-analysis [2], in which we 
assessed the potential relationship between extra-nodal extension (ENE) of nodal metastasis and prognostic 
indexes in colorectal cancer.  We found consistent evidence that ENE is associated with mortality and 
recurrence of disease, across multiple sensitivity analyses [2], which remained robust after adjustment for 
publication bias.  Moreover, we conducted meta-regression analyses to explain the low-moderate 
heterogeneity we encountered (see supplementary table 8) in line with best practice.  Nonetheless, Qun et al 
[1] have proposed two new subgroup analyses using the same data based on geographical location (Europe 
vs Japan) and site of tumor (colon, rectum, both colon and rectum cancer) to test the robustness of our 
results.  Qun et al replicated all of our findings, except from the all-cause mortality in colon cancer (HR 
1.396: 0.848-2.3) and colon and rectum cancer together (HR 1.513: 0.968-2.365). 
Although these additional analyses are of potential interest, we respectfully share a number of limitations.  
First, our initial analyses had low-moderate heterogeneity and our meta-regression analyses already 
significantly explained large portions of the heterogeneity we encountered.  Second, Qun et al did not report 
any heterogeneity metric in their new analyses, so it is unclear to what extent their additional analyses 
addressed their own primary concern that our paper found low-moderate heterogeneity.  Third, Qun et al 
included a limited number of studies in each subgroup (only 5 studies reported HR estimates: 2 studies for 
colon, 2 for rectum and 1 regarding colorectal cancer). Indeed, they only included 5 studies out of the 13 
considered in our meta-analysis, thus type II error might be a factor in their null findings.  Moreover, the p 
for the interaction for this subgroup analysis is 0.229, suggesting that this factor is not a probable moderator 
of our findings. Notably, the staging system does not separately consider colon and rectum cancer [2], further 
justifying our approach. Moreover, the meso-rectal adipose tissue, the main anatomical difference between a 
surgical specimen of colonic and of rectal cancer, contains very few lymph nodes: also from this point of 
view (i.e. number of lymph nodes and possible metastasis) colonic and rectal cancer can be studied together. 
Interestingly, the morphologic aspect most similar to ENE, that is represented by the free tumor deposits in 
adipose tissue (N1c category), is already considered in TNM staging system for both rectal and colonic 
cancer. Lastly, in other cancer types ENE appeared as a significant prognostic index [3,4], and also of 
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importance independently from specific anatomical sub-distinction (e.g. carcinoma of pancreas vs of ampulla 
of Vater) [5]. 
In conclusion, we partly agree with the analyses of Qun et al., and are grateful they echo our calls for further 
research considering the prognostic role of ENE in colorectal cancer.  However, we have a number of 
potential concerns that do not shift our stance, based on the data, that future research should consider colon 
and rectum cancer as only one entity.  
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